Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease

dc.contributorAalto-yliopistofi
dc.contributorAalto Universityen
dc.contributor.authorLuukkonen, Panu K.en_US
dc.contributor.authorDufour, Sylvieen_US
dc.contributor.authorLyu, Kunen_US
dc.contributor.authorZhang, Xian Manen_US
dc.contributor.authorHakkarainen, Anttien_US
dc.contributor.authorLehtimäki, Tiina E.en_US
dc.contributor.authorCline, Gary W.en_US
dc.contributor.authorPetersen, Kitt Falken_US
dc.contributor.authorShulman, Gerald I.en_US
dc.contributor.authorYki-Järvinen, Hanneleen_US
dc.contributor.departmentDepartment of Neuroscience and Biomedical Engineeringen
dc.contributor.organizationYale Universityen_US
dc.contributor.organizationUniversity of Helsinkien_US
dc.contributor.organizationMinerva Foundation Institute for Medical Research Helsinkien_US
dc.date.accessioned2020-04-28T07:02:52Z
dc.date.available2020-04-28T07:02:52Z
dc.date.issued2020-03-31en_US
dc.description.abstractWeight loss by ketogenic diet (KD) has gained popularity in management of nonalcoholic fatty liver disease (NAFLD). KD rapidly reverses NAFLD and insulin resistance despite increasing circulating nonesterified fatty acids (NEFA), the main substrate for synthesis of intrahepatic triglycerides (IHTG). To explore the underlying mechanism, we quantified hepatic mitochondrial fluxes and their regulators in humans by using positional isotopomer NMR tracer analysis. Ten overweight/obese subjects received stable isotope infusions of: [D7]glucose, [13C4]β-hydroxybutyrate and [3-13C]lactate before and after a 6-d KD. IHTG was determined by proton magnetic resonance spectroscopy (1H-MRS). The KD diet decreased IHTG by 31% in the face of a 3% decrease in body weight and decreased hepatic insulin resistance (-58%) despite an increase in NEFA concentrations (+35%). These changes were attributed to increased net hydrolysis of IHTG and partitioning of the resulting fatty acids toward ketogenesis (+232%) due to reductions in serum insulin concentrations (-53%) and hepatic citrate synthase flux (-38%), respectively. The former was attributed to decreased hepatic insulin resistance and the latter to increased hepatic mitochondrial redox state (+167%) and decreased plasma leptin (-45%) and triiodothyronine (-21%) concentrations. These data demonstrate heretofore undescribed adaptations underlying the reversal of NAFLD by KD: That is, markedly altered hepatic mitochondrial fluxes and redox state to promote ketogenesis rather than synthesis of IHTG.en
dc.description.versionPeer revieweden
dc.format.extent8
dc.format.mimetypeapplication/pdfen_US
dc.identifier.citationLuukkonen, P K, Dufour, S, Lyu, K, Zhang, X M, Hakkarainen, A, Lehtimäki, T E, Cline, G W, Petersen, K F, Shulman, G I & Yki-Järvinen, H 2020, 'Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease', Proceedings of the National Academy of Sciences of the United States of America, vol. 117, no. 13, pp. 7347-7354. https://doi.org/10.1073/pnas.1922344117en
dc.identifier.doi10.1073/pnas.1922344117en_US
dc.identifier.issn0027-8424
dc.identifier.issn1091-6490
dc.identifier.otherPURE UUID: c3ae4b6d-e6da-446c-91c0-21aff5b1c661en_US
dc.identifier.otherPURE ITEMURL: https://research.aalto.fi/en/publications/c3ae4b6d-e6da-446c-91c0-21aff5b1c661en_US
dc.identifier.otherPURE FILEURL: https://research.aalto.fi/files/42217565/Luukkonen_Effect_of_a_Ketogenic_Diet.7347.full.pdf
dc.identifier.urihttps://aaltodoc.aalto.fi/handle/123456789/43917
dc.identifier.urnURN:NBN:fi:aalto-202306053557
dc.language.isoenen
dc.publisherNational Academy of Sciences
dc.relation.fundinginfoRautamo, and Kaisa Jousimies for assistance with infusates; Titta Kaukinen and Jussi Perkiö for assistance with imaging; Heini Oksala and Karri Mikkonen for assistance with diets; Siiri Luukkonen for graphical assistance; and the volunteers for their help. This study was supported by Academy of Finland Grant 309263 (to H.Y.-J.); EU H2020 project ‘Elucidating Pathways of Steatohepatitis’ EPoS Grant 634413 (to H.Y.-J.); and H2020-JTI-IMI2 EU project 777377-2 Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS) (to H.Y.-J.), Erityisvaltionosuus (H.Y.-J.); Sigrid Jusélius Foundation (H.Y.-J., P.K.L.); Finnish Diabetes Research Foundation (P.K.L.); Instrumentarium Foundation (P.K.L.); Novo Nordisk (P.K.L.) Foundation; and the United States Public Health Service Grants R01 DK113984 (to G.I.S.), P30 DK45735 (to G.I.S.), and UL1 RR024139 (to Yale Hospital Research Unit).
dc.relation.ispartofseriesProceedings of the National Academy of Sciences of the United States of Americaen
dc.relation.ispartofseriesVolume 117, issue 13, pp. 7347-7354en
dc.rightsopenAccessen
dc.subject.keywordCarbohydrate restrictionen_US
dc.subject.keywordCitrate synthaseen_US
dc.subject.keywordInsulin resistanceen_US
dc.subject.keywordPyruvate carboxylaseen_US
dc.subject.keywordRedoxen_US
dc.titleEffect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver diseaseen
dc.typeA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessäfi
dc.type.versionpublishedVersion

Files